Formerly an SNF-based platform, connectRN is now focused on home health

0

The connectRN platform was designed to find work for nurses and other healthcare professionals, especially in skilled nursing (SNF) facilities.

But over time, workers were asking enough questions about home health opportunities that the company thought it should go deeper into home care. Coincidentally, Amedisys Inc. (Nasdaq: AMED) stepped onto the scene and participated in connectRN’s $76 million funding round, announced last December.

Since then, connectRN has hired a vice president of its home health business in Cora Jaulin, who had worked for more than a decade prior in the non-medical home care world with Arosa and HouseWorks.

And overall, home healthcare growth has become a central focus for the company, one of the key growth areas it expects to drive in the short and long term.

“We certainly continue to learn about the needs in the home health field,” Jaulin told Home Health Care News. “There is still a labor shortage. So now is kind of the perfect time for us to jump into this space to help our home health partners really think about how to provide opportunities for a home health clinician and continue to hold our global promise to provide choice and opportunity.

To date, Waltham, Massachusetts-based connectRN has raised over $95 million in funding. Through a technology-based platform and network, its goal is to improve the lives of clinicians by giving them more access, opportunity and support.

In home healthcare, learning what access, opportunity and support looks like is still something connectRN learns every day. Understanding this will theoretically drive returns for the company, its platform workers, and the home health businesses it has partnered with.

“Nothing surprised me of these [learnings] necessarily, but the quality of care provided is kind of a unique challenge,” said Jaulin. “The problem, as we compare the space of a skilled nursing facility to home, is that our clinicians provide one-on-one care, which presents unique challenges. Not only managing the quality of care provided, but also supporting a clinician when she is the only person at home.

Ted Jeanloz, CEO of connectRN, insisted that connecting “free agent” nurses with each other has always been a company goal. But it has become a priority since home health has become a priority, given that it can often be a lone job.

“It gives more independent nurses the comfort and security of a network of people they trust,” Jeanloz told HHCN. “And we think we can actually deliver an improved experience, and make people prefer to work in that model.”

Dumb enough to ask the right questions

The company has two distinct advantages at this point: it is associated with one of the largest players in the entire industry in Amedisys, for its part, and is also new enough to the industry that it does not am not afraid to ask stupid questions.

However, sometimes these silly questions from the outside can lead to breakthroughs.

“We’re approaching this from a very product- and technology-centric perspective, and we’re maybe dumb enough to ask questions like, ‘Why are you doing it this way? And, ‘What if we do it? like that ?’ Jeanloz said, “So we’ve both been able to improve each other’s processes. Because we’re impartial about how it’s always been done. And they’re able to kind of show us what it’s like best in class today.

Access to Amedisys best practices allows the company to gain a baseline, but also to challenge one of the most authoritative voices in the industry.

The partnership is also, inadvertently, a pretty good advertising tool.

“I think at any time, in any market, when a startup like ours partners with a true industry leader, it grabs attention,” Jeanloz said. “It definitely helped us open doors and build new relationships.”

Going forward, the company is also working to understand upcoming regulatory changes in the industry and how they might contribute to the effort from a workforce perspective.

By the end of this year, connectRN hopes to have 2,000 home health clinicians on its platform.

“But that’s just scratching the surface,” Jaulin said.

Share.

Comments are closed.